Tag: Prescription Drugs
Medicare Payments for Brand-Name Neurology Meds Soaring
From 2013 to 2017, number of claims increased 7.6 percent, but total payments increased 50.4 percent
FDA Warns Consumers to Not Use Ivermectin for COVID-19
Agency has received reports of patients requiring medical support after self-medicating with ivermectin for use in horses
Targeted Albumin Not Better for Hospitalized Cirrhosis Patients
No difference in incidence of end-point events, but more adverse events, seen in targeted albumin group versus standard-care group
Ivermectin Does Not Speed Symptom Resolution in Mild COVID-19
No significant improvement seen in median time to resolution of symptoms with ivermectin versus placebo
Semaglutide May Aid Weight Loss in Obese Patients With T2DM
Estimated change in mean body weight to week 68 was −9.6 percent with semaglutide 2.4 mg versus −3.4 percent with placebo
Terlipressin Bests Placebo in Type 1 Hepatorenal Syndrome
Terlipressin is more effective for reversal of HRS but is associated with more adverse events and death due to respiratory disorders
Nivolumab Plus Cabozantinib Tops Sunitinib for Renal Cell Carcinoma
Combination therapy superior with respect to progression-free, overall survival and overall response for first-line treatment of advanced RCC
IL-6 Receptor Antagonists Benefit Critically Ill With COVID-19
Improved outcomes, including more organ support-free days, reduced mortality, seen with tocilizumab, sarilumab
Lenvatinib Plus Pembrolizumab Tops Sunitinib in Advanced RCC
Progression-free, overall survival significantly longer with combo versus sunitinib for advanced renal cell carcinoma
Relugolix Combo Therapy Beneficial for Fibroid-Related Menorrhagia
Significantly more women had reduced menstrual bleeding with once-daily relugolix combination therapy versus placebo
